What if treating your allergies was as easy as….brushing your teeth? Well, with Intrommune Therapeutics, it now just might be! This New York City-based biopharmaceutical company is developing a toothpaste that uses oral mucosal immunotherapy (OMIT) to help people with peanut allergies overcome them. OMIT is based on allergy immunotherapy, which adheres to the idea that if patients receive tiny, carefully controlled amounts of the substance they are allergic to, their immune system learns that the substance is safe, and their allergic reactions become milder. Intrommune’s great-tasting, cavity-fighting toothpaste exposes patients to a low, safe dose of a peanut-derived protein in the toothpaste, with the goal of desensitizing the immune system’s reaction. They are developing this toothpaste in accordance to FDA guidelines, and there is no current FDA-approved treatment for any peanut for food allergy.